Journal: OncoTargets and Therapy
Article Title: miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression
doi: 10.2147/ott.s102430
Figure Lengend Snippet: Figure 4 MEF2D is required for miR-30a-directed osteosarcoma cell proliferation, migration, and invasion. Notes: (A) MEF2D expression was increased by transfection with MEF2D plasmids in miR-30a mimics osteosarcoma cell. (B) The MTT assay was used to detect MG-63 cells cotransfection with miR-30a mimic and pcDNA-MEF2D plasmid. (C) The wound healing assay was performed to detect the effects on cell migration of MG-63 cells treated as described. (D) The transwell invasion assay was used to detect the effects on cell invasion of MG-63 cells treated as described. Data are presented as mean ± SD from three independent experiments. *P,0.01 vs miR-30a group. **P,0.01 vs miR-30a + MEF2D group. Abbreviations: h, hours; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; OD, optical density.
Article Snippet: Then, the protein samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (10%) and detected by Western blot using polyclonal (rabbit) anti-MEF2D antibody (Santa Cruz Biotechnology Inc., Dallas, TX, USA).
Techniques: Migration, Expressing, Transfection, MTT Assay, Cotransfection, Plasmid Preparation, Wound Healing Assay, Transwell Invasion Assay